| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $36K | — | +34.8% |
| Cost of Revenue | $44K | — | +23.0% |
| Gross Profit | -$8K | — | +11.7% |
| R&D Expense | $38K | — | -68.2% |
| SG&A Expense | $59K | — | +12.4% |
| Operating Income | -$545K | — | +36.8% |
| Pre-tax Income | -$1.2M | — | -41.9% |
| Net Income | -$1.2M | — | -41.9% |
| EPS (Basic) | $0.00 | — | — |
| EPS (Diluted) | $0.00 | — | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $8K | -65.7% | -11.9% |
| Inventory | $57K | -0.7% | +168.2% |
| Current Assets | $2.6M | +57.4% | -21.3% |
| Total Assets | $3.0M | +58.0% | -10.6% |
| Current Liabilities | $172K | +45.7% | +48.8% |
| Total Liabilities | $253K | +22.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$430K | — | +5.6% |
| Capital Expenditures | $151K | — | — |
| Investing Cash Flow | -$151K | — | — |
| Financing Cash Flow | $1.5M | — | +2.7% |
| Free Cash Flow | -$581K | — | — |
| +119.4% |
| Stockholders' Equity | $2.7M | +62.4% | -15.4% |